Chapter 1 examines the history and background of oncology clinical trials.
Manual for Clinical Trials Nursing (Third Edition)
No votes yet
The third edition of the Manual for Clinical Trials Nursing provides you with an updated examination of issues surrounding clinical trials.
Member Price: $99.00Nonmember Price: $162.00
Oncology Nursing Society
Chapter 2 details drug development in clinical trials. CHapter 3 examines types of clinical research, focusing on background.
Chapter 4 explores types of experimental clinical research and Chapter 5 examines types of observational clinical research.
Chapter 6 explores issues surrounding the expandad access to investigational drugs. Chapter 7 examines sponsoring agencies.
Chapter 8 delves into the legal, regulatory, and legislative issues surrounding clinical trials.
Chapter 9 examines issues surrounding the term "good clinical practice."
Chapter 10 examines the make-up of the research team in clinical trials.
Chapter 11 explains issues surrounding standard operating procedures of clinical trials.
Chapter 12 explores the ethics of clinical research.
Chapter 13 details the elements of protocol while Chapter 14 examines informed consent.
Chapter 14 details protocol development and response assessment in clinical trials.
Chapter 16 examines the protocol review and approval process in clinical trials.
Chapter 17 details issues surrounding workload determination and resource allocation in clinical trials.
Chapter 18 examines issues surrounding billing, budgets, and funding in clinical trials.
Chapter 19 outlines agreements and contracts. Chapter 20 examines risk assessment and monitoring. Chapter 21 details internal financial audit and quality assurance, while Chapter 22 examines financial conflict of interest.
Chapter 23 describes issues surrounding public and patient education in clinical trials.
Chapter 24 examines issues surrounding the accrual base, recruitment, and promotional strategies of clinical trials.
Chapter 25 details adherence and retention in clinical trials. Chapter 26 examines issues surrounding clinical trial registries.
Chapter 27 examines issues surrounding investigational agents, detailing procurement, accountability, and administration of research study drugs.
Chapter 28 examines adverse events in clinical trials.
Chapter 29 explores issues surrounding patient and family education of clinical trials.
Chapter 30 examines issues surrounding psychosocial distress.
Chapter 31 focuses on issues surrounding pharmacogenetics and pharmacogenomics.
Chapter 32 examines issues surrounding genetic testing.
Chapter 33 examines issues surrounding cytogenetics. Chapter 34 explores tumor profiling.
Chapter 35 examines the storage of genetic material.
Chapter 37 examines documentation of clinicial trials. Chapter 38 explores issues surrounding data management and electronic data management systems.
Chapter 39 examines how to create and maintain regulatory files.
Chapter 40 details data and safety monitoring plans. Chapter 41 examines issues surrounding preparing for audits, inspections, and monitoring visits.
Chapter 42 details clinical trial nursing education. Chapter 43 examines mentorship.
Chapter 44 provides publishing guidance for clinical trials nurses.
Chapter 45 examines clinical trials in Australia.
Chapter 46 details clinical trials in Austria.
Chapter 47 examines clinical trials in Belarus.
Chapter 48 explains clinical trials in Canada.
Chapter 49 examines clinical trials in China.
Chapter 50 examines clinical trials in European Union Directives.
Chapter 51 examines clinical trials in France.
Chapter 52 examines clinical trials in Germany.
Chapter 53 examines clinical trials in India.
Chapter 54 details clinical trials in Ireland.
Chapter 55 details clinical trials in Italy.
Chapter 56 details clinical trials in Japan.
Chapter 57 details clinical trials in Mexico.
Chapter 58 examines clinical trials in New Zealand.
Chapter 59 details clinical trials in Romania.
Chapter 60 details clinical trials in Spain.
Chapter 61 details clinical trials in Thailand.
Chapter 62 details clinical trials in the United Kingdom.
Collects the book's appendices.